Poniard Pharmaceuticals, Inc.
PARD · OTC
9/30/2011 | 6/30/2011 | 3/31/2011 | 12/31/2010 | |
|---|---|---|---|---|
| Market Cap | $7 | $14 | $23 | $26 |
| - Cash | $2 | $4 | $5 | $1 |
| + Debt | $2 | $2 | $2 | $2 |
| Enterprise Value | $7 | $12 | $19 | $27 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$3 | -$4 | -$3 | -$4 |
| % Margin | – | – | – | – |
| Net Income | -$4 | -$4 | -$3 | -$5 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.4 | -2.8 | -2.4 | -4.09 |
| % Growth | 14.3% | -16.7% | 41.3% | – |
| Operating Cash Flow | -$2 | -$2 | -$2 | -$5 |
| Capital Expenditures | $0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$2 | -$2 | -$2 | -$5 |